InvestorsHub Logo
Followers 20
Posts 5508
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Thursday, 02/29/2024 9:24:41 AM

Thursday, February 29, 2024 9:24:41 AM

Post# of 15182
Good earning CC Lalwani went into greater detail into what is fueling Corti growth, indicating they see a long runway for growth. Still would not provide details regarding 1ml vial's impact on growth due to it being early in the launch.

Q1 Corti sales expected to dip over 2023 Q4, as coverage for 2024 is established. Then continued quarter over quarter growth continues. This Q1 dip appears common in the rare disease business.

Just like last year, increased guidance, as the year progresses.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News